Physicians interpret key research findings from recent San Antonio Breast Cancer Symposium for the public

WHAT: San Antonio breast cancer physicians who attended one of the world’s biggest scientific meetings about breast cancer in downtown San Antonio Dec. 9-13, 2009 will explain the most significant findings and answer questions. Agenda is below.

WHEN: Saturday, January 16, 2010
9 a.m. to 1 p.m.
Registrations at the door will be accepted. There is no charge to attend this event.

WHERE: La Quinta Inn & Suites Conference Center
4431 Horizon Hill (off Medical Drive and IH-10)
Continental breakfast provided.

WHO: Sponsored by the Alamo Breast Cancer Foundation and The University of Texas Health Science Center at San Antonio

The Cancer Therapy & Research Center (CTRC) at the UT Health Science Center is a co-sponsor of the CTRC-AACR San Antonio Breast Cancer Symposium, along with the American Association of Cancer Research and Baylor College of Medicine in Houston.

Time Topic Speaker
8:30 a.m. Registration & Continental Breakfast
9:00 a.m.- 9:45 New Therapies in Research Monica Mita, M.D.
Assistant Professor of Medicine
UT Health Science Center
9:45 a.m. -10:30 Improvements in Conventional Therapy Sharon Wilks, M.D., FACP
Oncologist, Community advocate
Cancer Care Centers of South Texas
10:30 a.m. – 10:45 Break
10:45 a.m.- 11:30 Surgery, Imaging, Screening Ismail Jatoi, M.D., Ph.D, FACS
Professor of Surgery, Chief of Surgical Oncology
UT Health Science Center
11:30 a.m. – 12:15 Bisphosphonates, Diet, Alcohol & Pregnancy Peter Ravdin, M.D., Ph.D. Clinical Professor of Medicine
UT Health Science Center
12:15 – 1:00 General Questions

The Cancer Therapy & Research Center at The University of Texas Health Science Center at San Antonio is one of the nation’s leading academic research and treatment centers, serving more than 4.4 million people in the high-growth corridor of Central and South Texas including Austin, San Antonio, Laredo and the Rio Grande Valley. CTRC is one of the elite cancer centers in the country to be named a National Cancer Institute-designated Cancer Center, and is one of the only three in Texas. A world leader in developing new drugs to treat cancer, the CTRC Institute for Drug Development is internationally recognized for conducting one of the largest oncology Phase I clinical drug programs in the world, and participates in the clinical and/or preclinical development of many of the cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit

Share This Article!